H.C. Wainwright Maintains Buy rating on BioLife (BLFS) Stock
On May 27, H.C. Wainwright reaffirmed its Buy rating on BioLife Solutions, Inc. (NASDAQ:BLFS) while keeping the price target the same at $30.
Posts Tagged ‘NASDAQ:BLFS’
BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions First Quarter 2025 Shareholder and Analyst Conference Call.
BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions Q3 2024 Shareholder and Analyst Conference Call.
BioLife Solutions (BLFS) Surpassed Revenue and Earnings-Per-Share Expectations in Q2
Conestoga Capital Advisors, an asset management company, released its “Micro-Cap Strategy” second-quarter 2024 investor letter.
10 Best Organ Transplant and Diagnosis Stocks To Buy Now
In the dynamic landscape of healthcare, the importance of organ transplantation cannot be overstated.
BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2024 Earnings Call Transcript
BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.19, expectations were $-0.26.
Corporate Insiders Are Selling These 10 Small-Cap Stocks
In this article, we will take a detailed look at Corporate Insiders Are Selling These 10 Small-Cap Stocks. For a quick overview of such stocks, read our article Corporate Insiders...
BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2024 Earnings Call Transcript
BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.36. BioLife Solutions, Inc.
BioLife Solutions (BLFS) was Impacted by Inventory Destocking and Elongated Sales Cycles
Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here.
BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions Third Quarter 2023 Shareholder and Analyst Conference Call.
BioLife Solutions, Inc. (NASDAQ:BLFS) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions Second Quarter 2023 Shareholders and Analyst Conference Call.
BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2023 Earnings Call Transcript
Operator: Hello. My name is Mallory, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q1 2023 BioLife Solutions, Inc.
BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2022 Earnings Call Transcript
Operator: Good day, and welcome to the BioLife Solutions' Fourth Quarter 2022 and Full Year Earnings Call. Today's call is being recorded.
Should You Invest in BioLife Solutions (BLFS)?
Conestoga Capital Advisors, an asset management company, released its “Conestoga Micro Cap Growth Fund” third-quarter investor letter.
Top 5 Stock Picks of Eli Casdin’s Casdin Capital
In this article, we discuss the top 5 stock picks of Eli Casdin's Casdin Capital.
Top 5 Stock Picks of Eli Casdin’s Casdin Capital
In this article, we discuss the top 5 stock picks of Eli Casdin's Casdin Capital.
Hedge Fund and Insider Trading News: Bill Ackman, Morgan Creek Digital, Thryv Holdings Inc (THRY), Vor Biopharma Inc (VOR), Pool Corporation (POOL), and More
Gemini said on Thursday it had raised $400 million in a funding round led by hedge fund Morgan Creek Digital that valued the startup at $7.1 billion, becoming the latest crypto...
BioLife Solutions (BLFS) Shines Amidst the Pandemic
Wasatch Advisors, an employee-owned investment manager, published its ‘Wasatch Micro Cap Value Fund’ third-quarter 2020 Investor Letter – a copy of which can be downloaded...
Want to Buy BioLife Solutions (BLFS) Stock? Here’s What You Need to Know
Wasatch Micro Cap Fund recently released its Q3 2020 Investor Letter, a copy of which you can download here.
Is BLFS A Good Stock To Buy Now?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Is BioLife Solutions, Inc. (BLFS) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Smart Money Dumping BioLife Solutions, Inc. (BLFS)
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.
BioLife Solutions, Inc. (BLFS): Hedge Fund Interest Cooling Off
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through October 17th.
Hedge Funds Have Never Been This Bullish On BioLife Solutions, Inc. (BLFS)
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged during the first quarter.
Hedge Fund and Insider Trading News: Eddie Lampert, Steve Cohen, Scientific Games Corp (SGMS), TRACON Pharmaceuticals Inc (TCON), AllianceBernstein Holding LP (AB), and More
Back in November, billionaire Steve Cohen predicted a bear market was approaching.
Hedge Fund and Insider Trading News: BlueMountain Capital Management, Seth Klarman, BioLife Solutions Inc (BLFS), Templeton Emerging Markets Income Fund, Inc. (TEI), Herman Miller, Inc. (MLHR), and More
NEW YORK (Reuters) - BlueMountain Capital Management on Tuesday said it hired four portfolio managers to build out the hedge fund’s new fixed-income strategy focused on relative...
Why Traders Are Clamoring for These 5 Stocks This Morning
Wall Street is in full-on Bull Mode today, as all three indexes are in the green and the S&P recently hit a record intra-day high.
